OncoTherapy Science, Inc. (TYO:4564)

OncoTherapy Science Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 1, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	6,340	4,353	9,054	13,292	21,689	10,933
Market Cap Growth	35.66%	-51.92%	-31.88%	-38.71%	98.39%	-45.86%
Enterprise Value	5,395	3,755	8,077	11,071	18,295	6,463
Last Close Price	23.00	20.00	47.00	69.00	123.00	62.00
PS Ratio	8.97	7.14	7.98	11.53	65.33	34.60
PB Ratio	7.66	12.33	10.60	6.72	7.05	2.31
P/TBV Ratio	7.66	12.33	10.60	6.72	7.06	2.32
PEG Ratio	-	0.76	0.76	0.76	0.76	0.76
EV/Sales Ratio	7.63	6.16	7.12	9.60	55.11	20.45
Asset Turnover	0.65	0.51	0.54	0.38	0.08	0.06
Inventory Turnover	12.65	17.04	10.97	20.37	51.97	86.04
Quick Ratio	3.56	1.99	2.04	3.70	15.73	19.60
Current Ratio	4.06	2.28	2.34	4.31	16.46	20.16
Return on Equity (ROE)	-137.29%	-213.42%	-78.93%	-101.74%	-40.02%	-46.64%
Return on Assets (ROA)	-48.89%	-58.87%	-32.98%	-42.40%	-24.21%	-26.17%
Return on Capital (ROIC)	-71.31%	-115.99%	-48.84%	-50.78%	-26.24%	-28.51%
Earnings Yield	-16.06%	-29.59%	-12.35%	-19.34%	-7.20%	-20.47%
FCF Yield	-	-28.23%	-8.81%	-19.03%	-8.32%	-22.00%
Buyback Yield / Dilution	-19.95%	-10.45%	-2.76%	-6.31%	-8.14%	-10.54%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.